24/06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

24/06/2024

Jun 24, 2024, 03:22 | Insight
Deniz Can Guven: The OS benefits of cancer drugs approved by surrogate endpoints
Deniz Can Guven, The Editorial Board Member in BMC Cancer, shared on X: "Out in…
Jun 24, 2024, 03:17 | Blog
Kimryn Rathmell: LGBTQIA+ people face disparities across aspects of cancer and cancer care
Kimryn Rathmell shared on X:                     .…
Jun 24, 2024, 03:01 | Blog
Wafik S. El-Deiry: Outstanding discussions at the WIN Consortium in cancer personalized medicine molecular tumor board
Wafik S. El-Deiry posted on LinkedIn: "Outstanding discussions earlier today at the international WIN Consortium in…
Jun 24, 2024, 02:54 | Insight
Eleni Tolma: An interesting report that supports the implementation of the Mission on Cancer
Eleni Tolma, Associate Professor at The University of Nicosia Medical School, shared on LinkedIn:  “An…
Jun 24, 2024, 02:53 | Insight
Study examines how people respond to health information from faith-based congregations - Minority Health
Minority Health shared on X: "In case you missed it: A Public Health Reports study…
Jun 24, 2024, 02:50 | Blog
Immunotherapy minute with Joseph Muldoon - Cancer Research Institute
Cancer Research Institute (CRI) posted on LinkedIn: "Spend a minute with CRI Postdoctoral Fellow Dr.…
Jun 24, 2024, 02:43 | Blog
The AACR-AstraZeneca Breast Cancer Fellowship for Endocrine Therapy Research
American Association for Cancer Research posted on LinkedIn: "The AACR-AstraZeneca Breast Cancer Fellowship for Endocrine…
Jun 24, 2024, 02:41 | Insight
Rafael Fonseca: One of the most impressive aspects of more effective front line therapies in multiple myeloma
Rafael Fonseca shared on X: "One of the most impressive aspects of more effective front-line…
Jun 24, 2024, 02:32 | Insight
Laura Bukavina: Clear failure of clinical trials to represent the true population of Genitourinary cancer patients
Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X:           …
Jun 24, 2024, 02:19 | Insight
Nitin Jain: Pirtobrutinib Venetoclax and Obinutuzumab in First-Line treatment for CLL
Nitin Jain shared on X:                   . "Delighted…
All: 116 Posts: 91 - 100
Special Coverage